These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1708430)

  • 41. Acquired hemophilia A in a patient with essential thrombocythemia.
    Mori N; Totsuka K; Ishimori N; Yoshinaga K; Teramura M; Noguchi S; Oda H; Motoji T
    Acta Haematol; 2012; 127(3):170-2. PubMed ID: 22301942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Successful haemodialysis and renal transplantation in a patient with haemophilia A.
    Koene RA; Gerlag PG; Jansen JL; Moulijn AC; Skotnicki SH; Debruyne FJ; Kunst VA; Geerdink P; Wijdeveld PG
    Proc Eur Dial Transplant Assoc; 1977; 14():401-6. PubMed ID: 341141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibody studies of factor VIII inhibitor in a case with Waldenström's macroglobulinemia.
    Endo T; Yatomi Y; Amemiya N; Mizoe A; Iino M; Ozawa H; Hosogaya S; Ozaki Y
    Am J Hematol; 2000 Mar; 63(3):145-8. PubMed ID: 10679805
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Postpartum hemorrhage syndrome caused by factor VIII inhibitor in the blood].
    Rolović Z; Ruvidić R; Marinković N
    Bilt Hematol Transfuz; 1975; 3(3):35-40. PubMed ID: 1083731
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Successful peritoneal dialysis in a hemophilia A patient with factor VIII inhibitor.
    Solak Y; Turkmen K; Atalay H; Turk S
    Perit Dial Int; 2010; 30(1):114-6. PubMed ID: 20056993
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunological analysis of acquired factor VIII inhibitor in a case with immunologic disorder.
    Okamura T; Yamauchi Y; Fukuda T; Suehiro K; Murakawa M; Shibuya T; Nagasawa K; Harada M; Niho Y
    Acta Haematol; 1991; 85(3):153-5. PubMed ID: 1710410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Purification of human factor VIII:C and its characterization by Western blotting using monoclonal antibodies.
    Rotblat F; O'Brien DP; O'Brien FJ; Goodall AH; Tuddenham EG
    Biochemistry; 1985 Jul; 24(16):4294-300. PubMed ID: 2413885
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hemodialysis in a patient with severe hemophilia A and factor VIII inhibitor.
    Gopalakrishnan N; Usha T; Thopalan B; Dhanapriya J; Dineshkumar T; Thirumalvalavan K; Sakthirajan R
    Hemodial Int; 2016 Oct; 20(4):E11-E13. PubMed ID: 27149570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A case of factor VIII inhibitor-positive acquired hemophilia treated by plasmapheresis.
    Narukawa N; Abe T; Shouno M; Kitabata Y; Okamoto M; Kobata H; Akizawa T
    Ther Apher; 1999 Nov; 3(4):323-5. PubMed ID: 10608728
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Elderly non-hemophiliac patient with factor VIII inhibitor presenting various type hemorrhages].
    Sadakata H; Yatabe H; Shinozaki T; Narahara N; Naruse T; Tsuchiya J
    Nihon Ronen Igakkai Zasshi; 1995 Jan; 32(1):47-50. PubMed ID: 7739144
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acquired factor VIII inhibitor in a patient with chronic myelogenous leukemia receiving interferon-alfa therapy.
    English KE; Brien WF; Howson-Jan K; Kovacs MJ
    Ann Pharmacother; 2000 Jun; 34(6):737-9. PubMed ID: 10860135
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human factor VIII procoagulant protein. Monoclonal antibodies define precursor-product relationships and functional epitopes.
    Fulcher CA; Roberts JR; Holland LZ; Zimmerman TS
    J Clin Invest; 1985 Jul; 76(1):117-24. PubMed ID: 2410456
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effectiveness of plasma exchange for acquired type A hemophilia.
    Goto S; Ookawara S; Ueda Y; Ito K; Miyazawa H; Kitano T; Shindo M; Kaku Y; Hirai K; Hoshino T; Ashizawa M; Mori H; Yoshida I; Tabei K
    CEN Case Rep; 2015 Nov; 4(2):196-199. PubMed ID: 28509101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Factor VIII inhibitor in insulin-dependent diabetes mellitus.
    Wajima T; Hall G
    Am J Hematol; 1989 Mar; 30(3):186-7. PubMed ID: 2492761
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acquired factor VIII inhibitor preceding chronic lymphocytic leukemia.
    Mateo J; Martino R; Borrell M; Garí M; Casas F; Fontcuberta J
    Ann Hematol; 1993 Dec; 67(6):309-11. PubMed ID: 8280815
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A monoclonal immunoglobulin A (kappa) factor VIII:C inhibitor associated with primary amyloidosis: identification and characterization.
    Glueck HI; Coots MC; Benson M; Dwulet FE; Hurtubise PE
    J Lab Clin Med; 1989 Mar; 113(3):269-77. PubMed ID: 2494277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of factor VIII inhibitors with the partial thromboplastin time.
    Lossing TS; Kasper CK; Feinstein DI
    Blood; 1977 May; 49(5):793-7. PubMed ID: 856360
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Steroid-responsive type II anti-factor VIII:C autoantibody in a nonhemophiliac child.
    Carter CJ; Devine DV; Rogers PC; Wadsworth LD
    Am J Pediatr Hematol Oncol; 1990; 12(2):205-9. PubMed ID: 2116097
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of human anti-factor VIII antibodies purified by immune complex formation.
    Lavergne JM; Meyer D; Reisner H
    Blood; 1976 Dec; 48(6):931-9. PubMed ID: 826294
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An unusual cause of bruising in an 80-year-old woman.
    Kelly J; Gattens M; Geraghty R
    Age Ageing; 2000 May; 29(3):261-3. PubMed ID: 10855910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.